BRIEF-Gsk Says Collaboration Launched To Develop Treatment Regimens For Tuberculosis - Reuters

Feb 27 (Reuters) - GlaxoSmithKline PLC:

* GSK SAYS GLOBAL COLLABORATION LAUNCHED TO DEVELOP TREATMENT REGIMENS FOR TUBERCULOSIS

* GSK-COLLABORATION AIMS TO ACCELERATE DEVELOPMENT OF NOVEL “PAN-TB” DRUG REGIMENS FOR TREATMENT OF TUBERCULOSIS READY FOR PHASE 3 DEVELOPMENT Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.


Comments

Popular posts from this blog

Manual on meat inspection for developing countries

Blogs, Releases Address Impact Of COVID-19 On AIDS, TB, Malaria, Food Security Responses, Other Issues Related To Pandemic - Kaiser Family Foundation

Having This One Particular Blood Type Can Help Protect You From Severe Malaria - ScienceAlert